startup
Agentcap
Agentcap exports AI-agent activity data via eBPF to Grafana for monitoring and analysis.
- 机会评分
- 40 / 100
- 累计融资
- unknown
- 融资阶段
- unknown
- 成立年份
- unknown
- 地区
- Global
- 阶段
- unknown
八个维度
Company · Problem · Solution · Target Customer · Business Model · Funding · Competitors · Why NowCompany
Agentcap is a tool that exports AI-agent activity data using eBPF technology. It integrates with Grafana for real-time monitoring and visualization.
Problem
AI agents often operate in black boxes, making their activities hard to track and debug. Monitoring their behavior is crucial for optimization and compliance.
Solution
Agentcap uses eBPF to capture AI-agent activity data efficiently. It provides a unified interface for exporting this data to Grafana for analysis.
Target Customer
Target customers include AI developers, system administrators, and organizations using AI agents. The primary buyers are tech teams and DevOps professionals.
Business Model
Agentcap likely follows an open-source or SaaS model, with premium features available for enterprise customers. Revenue could come from subscriptions or licensing.
Funding
该维度暂无可核实信息(unknown)
Competitors
该维度暂无可核实信息(unknown)
Why Now
The rise of AI agents and the need for transparency and monitoring in their operations make this solution timely. eBPF's efficiency in data capture is a strong technical enabler.
来源与 AI 标注
模型 · prompt 版本 · 生成时间 · 来源链接下列来源为自动抓取与 AI 解读所依据的公开信息,可逐条回溯原文。
- Hacker News · Show HN打开
模型 @cf/deepseek-ai/deepseek-r1-distill-qwen-32b · Prompt stp-v1 · 生成于 2026-10-05
相关项目与同赛道
按赛道继续看相关项目6 家
| 公司 | 赛道 | 评分 |
|---|---|---|
| ReboltAI驱动的企业操作系统 | AIB2B企业服务 | 95 |
| EliseAIAI-driven platform for enterprise efficiency and decision-making | AISaaS | 90 |
| TensorTestAI-powered creative task evaluation platform | AIB2BData | 90 |
| LucentAI that automatically improves products from user behavior. | B2BAIProductivity | 90 |
| Paratus HealthAI 驱动的医疗数据分析平台 | HealthcareAI | 90 |
| HealthKeyAI-Powered Patient Matching for Clinical Trials | AIHealthcareClinical Trials | 90 |
同赛道入口按赛道继续看
数据来自公开渠道与 AI 解读,仅供参考,不构成投资建议。信息可能滞后或有误,决策请以公司官网与官方披露为准。